<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" dir="ltr" lang="de">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="keywords" content="" />
<meta name="description" content="" />
<title>nanoathero | Home</title>
<link rel="stylesheet" type="text/css" href="css/style.css" />
</head>
<body>
    <div id="wrapper">
        <div id="header">
            
        </div>        <div class="navbar">
            <ul class="navbar_links">
<li class="active"><a href="index.php">Home</a></li>
<li><a href="project.php">The project</a></li>
<li><a href="about_us.php">About us</a></li>
<li><a href="achievement.php">Achievements</a></li>
<li><a href="news.php">News & events</a></li>
<li><a href="links.php">Links</a></li>
<li><a href="contact_us.php">Contact us</a></li>
<li><a href="https://nanoathero.egroupware.net/egw/login.php?phpgw_forward=%2Findex.php">Extranet</a></li>
<li><a href="videos.php">Videos</a></li>
        
            </ul>
        </div>
        <div id="layer">
            <table cellspacing="0" cellpadding="0" border="0" width="100%">
                <tr>
                    <td id="left" valign="top" class="arrow_button">
                        <div class="box_navigation" style="height:370px;">
                            <div class="mainbox_header">Home</div>
                            <div class="mainbox_content">
 <ul class="navigation">
                                    <li><a href="project.php">The project </a></li>
                                    <li><a href="about_us.php">About us</a></li>
                                    <li><a href="achievement.php">Achievement </a></li>
                                    <li><a href="news.php">News & events</a></li>
                                    <li><a href="links.php">Links</a></li>
                                    <li><a href="contact_us.php">Contact us</a></li>
                                    <li><a href="https://nanoathero.egroupware.net/egw/login.php?phpgw_forward=%2Findex.php" target="_blank">Extranet</a></li>
                                    <li><a href="videos.php">Videos</a></li>
                                </ul>
                            </div>                            
                        </div>
                        <div class="access_button"><a href="https://nanoathero.egroupware.net/egw/login.php?phpgw_forward=%2Findex.php"><img src="images/access_button.png" onmouseover="this.src='images/access_button_hover.png';" onmouseout="this.src='images/access_button.png';" alt="extranet access" title="extranet access" /></a></div>
                        <div class="newsbox_left" style="margin-top: 70px;">
                            
                            <div class="newsbox_content"><img src="images/seventh_framework_logo.png" border="0" alt="nanoathero" title="nanoathero"><p><span style="font-family: arial; color:#2e70b3;"><small>This project has received funding<br /> from the European Union's <br />Seventh Framework Programme <br />for research, technological <br />development and demonstration <br />under grant agreement no 309820</small></span></p></div>  
                        </div>
                    </td>
                    <td id="content" valign="top">
                        <div class="contentbox"><span class="header">Nanomedicine for target-specific imaging and treatment of atherothrombosis: development and initial clinical feasibility</span>
                        <p><strong>FP7 funded Project February 2013 â€“ March 2018<img src="images/nanoathero.jpg" border="0" width="220" height="330" style="margin-right: 20px; margin-bottom: 5px; float: left;" /></strong></p>
<p><strong>The Concept and the Goals</strong></p>
<p>NanoAthero aims to demonstrate the preliminary clinical feasibility of the use of nanosystems for targeted imaging and treatment of advanced atherothrombotic disease in humans. NanoAthero offers a unique opportunity by combining in-depth knowledge of nanocarrier bioengineering and production with state-of-the-art expertise in imaging and treatment of cardiovascular patients providing a full framework of 16 partners within one collaborative European consortium. The NanoAthero project gathers together chemists, engineers, pharmacists, biologists, toxicologists, ethicists and clinical key leaders from RTOs, hospitals, SMEs and a large pharmaceutical company around on central theme: prove that the benefit of the use of nanoparticle technologies can be measured in a clinical setting. The reasoning behind the consortium can be highlighted by the general following questions:</p>
<p>- Can local delivery of a drug with a nanosystem change the balance between therapeutic and adverse effects thereby permitting the safe use of a drug already on the market or to be on the market?</p>
<p>- Can we treat vulnerable plaques with a nanosystem?</p>
<p>- What are pathological events in atherosclerosis that a nanosystem could detect with medical imaging?</p>
<p>- What could be the benefit for a patient?</p>
<p>In acute coronary syndrome and stroke, atherosclerotic plaque disruption with superimposed thrombosis, is the leading cause of mortality in the Western world. NanoAthero aims both the imaging and the treatment of thrombus and plaque.</p>
<p>i) Nanosystems will be used for delivery and improved efficacy of drugs for plaque and stroke treatments in humans.</p>
<p>ii) New imaging agents will allow molecular imaging of key processes and early adverse events using clinically available imaging modalities.</p>
<p>The nanosystems are assemblies of following components: carrier, targeting, imaging agent/drug. The proposed nanocarriers in NanoAthero have proven safety records, and we have the preliminary in vitro and in vivo proofs of concept on the building components of these nanosystems. Over 5 years, the NanoAthero project will integrate several key elements: GMP production, the initiation of clinical investigations in patients at high cardiovascular risk, including the preparation of dossiers on regulatory issues, risk and ethical assessments, and the evaluation of the performance of optimized diagnostic and therapeutic compounds.</p>
                        
                        </div>
                           <!--<div class="newsbox">
                            <div class="newsboxcontent">
                                <span class="header" style="color: orange;">Nipitissequi quam, ipsanim eum aut ut dendae</span><p>Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem. Nulla consequat massa quis enim. Donec pede justo, fringilla vel, aliquet nec, vulputate eget, arcu. In enim justo, rhoncus ut, imperdiet a, Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.</p>
                            </div>    
                        </div>-->
                    </td>
                </tr>
            </table>
        </div>
        <div id="footer">&copy; Copyright 2016  by NanoAthero</div>
    </div>
</body>
</html>